Trade Summary

4 days ago, Zummo Jacqueline, serving as Chief R, D Officer at Protara Therapeutics, Inc. (TARA), sold 22,598 shares at $5.26 per share, for a total transaction value of $118,865.00. Following this transaction, Zummo Jacqueline now holds 95,961 shares of TARA.

This sale represents a 19.00% decrease in Zummo Jacqueline's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026, 1 day after the trade was made.

Protara Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.